Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 233

Results For "US"

8099 News Found

Natco receives emergency use approval for Baricitinib tablets
News | May 05, 2021

Natco receives emergency use approval for Baricitinib tablets

The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic


Dr. Reddy's launches Albendazole tablets in US
News | April 30, 2021

Dr. Reddy's launches Albendazole tablets in US

Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two


Govt. waives off basic customs duty & health cess on oxygen equipment
News | April 26, 2021

Govt. waives off basic customs duty & health cess on oxygen equipment

Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months


Vaishali Pharma bags order worth US $270,000 from Afghanistan
News | April 26, 2021

Vaishali Pharma bags order worth US $270,000 from Afghanistan

This achievement enables the company to strengthen its presence in the high growth market of South Asian countries


US to supply raw material for covishield vaccine
News | April 26, 2021

US to supply raw material for covishield vaccine

The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India


Caplin Steriles gets USFDA approval
News | April 23, 2021

Caplin Steriles gets USFDA approval

The injection comes in multiple formats


Indian pharma industry registers 18% exports growth: Narendra Modi
Policy | April 20, 2021

Indian pharma industry registers 18% exports growth: Narendra Modi

Essential medicines were made available to more than 150 countries around the world during the pandemic


Covaxin vaccine production to increase 7x by August 2021
News | April 18, 2021

Covaxin vaccine production to increase 7x by August 2021

The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021.


Merck publishes sustainability report for 2020
News | April 13, 2021

Merck publishes sustainability report for 2020

The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.


Zydus Cadila announces USFDA approval for Ibrutinib capsules
News | April 08, 2021

Zydus Cadila announces USFDA approval for Ibrutinib capsules

Zydus was the first ANDA applicant to submit a substantially complete ANDA with a paragraph IV certification for Ibrutinib Capsules, 70 mg.